Market Place
Sourcing Support
Leap Therapeutics Reports Q3 2024 Financial Results
13 Nov 2024 //
PR NEWSWIRE
Leap Therapeutics Announces $40 Million Private Placement
11 Apr 2024 //
PR NEWSWIRE
Leap Therapeutics Announces Initiation of Part B of the DeFianCe Study of DKN-01
12 Jul 2023 //
PR NEWSWIRE
Leap Announces Completion of Enrollment in Part A of DeFianCe Study of DKN-01
12 Apr 2023 //
PR NEWSWIRE
BeiGene lets option on Leap’s immuno-oncology candidate lapse
18 Mar 2023 //
FIERCE BIOTECH
Leap picks up anti-Claudin assets via Flame merger
18 Jan 2023 //
BIOPHARMADIVE
Leap Therapeutics Announces First Patient Enrolled in DeFianCe Study of DKN-01
17 Oct 2022 //
PRNEWSWIRE
Leap Tx to Present Data from Investigator-Sponsored Study of DKN-01 + Docetaxel
26 May 2022 //
PRNEWSWIRE
Leap Tx to Present at Raymond James 43rd Annual Institute Investors Conference
02 Mar 2022 //
PRNEWSWIRE
Leap Therapeutics Announces Closing of Public Offering of Common Stock
24 Sep 2021 //
PRNEWSWIRE
Leap Therapeutics plunges on stock and pre-funded warrants offering
21 Sep 2021 //
SEEKINGALPHA
Leap Therapeutics stock jumps 47% on positive DKN-01 + tislelizumab data
16 Sep 2021 //
SEEKINGALPHA
Leap Therapeutics to Present at the ESMO 2021 Virtual Congress
26 Jul 2021 //
PRNEWSWIRE
Leap & Flagship Develop Image Analysis RNAscope Assay for Trial Enrollment
12 May 2021 //
PRNEWSWIRE
Flagship Biosciences and Leap Therapeutics Announce Partnership and Approach
13 Apr 2021 //
PRNESWIRE
Leap Therapeutics Announces Completion of Enrollment for First-Line Patient
01 Apr 2021 //
LEAPTX
Leap Presents DKN-01 Clinical Data at the Society of Gynecologic Oncology 2021
22 Mar 2021 //
PRESS RELEASE
Leap Therapeutics Announces Publication of DKN-01 Mechanism of Action Data
22 Dec 2020 //
PRNEWSWIRE
Leap Announces Publication of DKN-01 Mechanism of Action Data
22 Dec 2020 //
PRNEWSWIRE
Leap to Participate at Piper Sandler 32nd Annual Virtual Healthcare
23 Nov 2020 //
PRNEWSWIRE
Leap Therapeutics Presents DKN-01 Monotherapy Data at AACR Virtual
09 Nov 2020 //
PRNEWSWIRE
Leap Therapeutics to Present Esophagogastric Cancer Data at SITC 2020 Meeting
15 Oct 2020 //
YAHOO
Leap Therapeutics Announces FDA Fast Track Designation Granted to DKN-01
24 Sep 2020 //
PRNEWSWIRE
Leap & BeiGene Announce 1st Patient Dosed in Study of DKN-01 + Tislelizumab
21 Sep 2020 //
PRNEWSWIRE
Leap Therapeutics Announces Proposed Public Offering of Common Stock
18 Jun 2020 //
PR NEWSWIRE
Leap Therapeutics Announces Proposed Public Offering of Common Stock
17 Jun 2020 //
PR NEWSWIRE
Leap Announces Oprhan Drug Designation of DKN-01 for the Treatment of Gastric
11 Jun 2020 //
PRNEWSWIRE
Leap Therapeutics to Present Updated Data for DKN-01 Monotherapy
23 Apr 2020 //
PR NEWSWIR
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.